Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with DepressionGlobeNewsWire • 03/31/25
Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating ResultsGlobeNewsWire • 03/27/25
Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a BetZacks Investment Research • 03/18/25
Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating ResultsGlobeNewsWire • 03/04/25
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common StockGlobeNewsWire • 02/07/25
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewsWire • 11/20/24
CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating ResultsGlobeNewsWire • 11/12/24
Neuronetics Reports Record Third Quarter 2024 Financial and Operating ResultsGlobeNewsWire • 11/12/24
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference CallGlobeNewsWire • 10/29/24
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with DepressionGlobeNewsWire • 10/14/24
Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder MeetingsPRNewsWire • 10/04/24
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and AdultsGlobeNewsWire • 09/19/24
NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful StoriesGlobeNewsWire • 09/03/24